Clinical Trial Update: Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab in combination with docetaxel in women with locally advanced or metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Taxotere (docetaxel)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Breast Cancer, Stage IV Breast Cancer | Phase 2 | Status: COMPLETED